4.10.23Segment

Pulmonology & Respiratory Medicine

Pulmonology practices and respiratory medicine programs treating COPD, asthma, lung disease, and complex respiratory conditions.

6
Verticals

Overview

Pulmonology & Respiratory Medicine covers pulmonology practices and respiratory-medicine programs treating COPD, asthma, lung disease, and complex respiratory conditions. Demand is driven by chronic respiratory disease prevalence and an aging population.

It has been a less-consolidated specialty, with sleep medicine and infusion as ancillary opportunities, and emerging interest in pulmonary and critical-care management organizations. Chronic-disease management underpins recurring demand.

Market snapshot

FragmentationFragmentedEstimate

Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so pulmonology is not separately sized.

Business model & economics

Revenue model

Office, diagnostic, and procedure reimbursement

Key economics

Recurring revenue
Moderate

chronic respiratory care recurs

EBITDA margin
15–25%
Capex intensity
Low

Characteristics

  • Chronic respiratory disease and aging drive demand.
  • Sleep medicine and infusion as ancillaries.
  • Less consolidated, with emerging MSO interest.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Emerging pulmonology MSO platforms
  • Multispecialty groups
  • Sleep- and infusion-aligned acquirers

What’s driving deals

  • Emerging pulmonology consolidation.
  • Chronic-respiratory and aging demand.
  • Ancillary sleep and infusion economics.

Verticals in this segment

Find Pulmonology & Respiratory Medicine acquisition targets

Search Acquisera’s index for companies classified under Pulmonology & Respiratory Medicine (4.10.23) and build a targeted deal pipeline.

Search companies